|
|
Bio-tech Startup Incubation Best Practice in the United Kingdom and Suggestion |
HU Yuan-lei1,CHEN Yan-cheng2,*(),PU Run3,*(),YAO Wei-hao4,ZHANG Hong-xiang5,6 |
1 School of Life Sciences,Peking University, Beijing 100871,China 2 Ministry of Science and Technology, Beijing 100862,China 3 China National Center for Biotechnology Development, Beijing 100039,China 4 Office of Science and Technology Development, Institute of Industrial Technology Research, Peking University,Beijing 100871,China 5 National Science Library, Chinese Academy of Science, Beijing 100190,China 6 Chinese Society of Biotechnology, Beijing 100101,China |
|
|
Abstract All major economies of the world have adopted biopharmaceutical industry as a strategic sector to prioritise. Biopharmaceutical industry has gradually become the new growth engine for the global economy. The United Kingdom ranks No.1 in Europe by the size of its biopharmaceutical industry. This article elaborates the role played by its local ecosystem in fostering the growth of the UK’s biopharmaceutical industry. We hope this article can serve as a reference for those who are involved in the innovation and venture building in China’s biopharmaceutical industry.
|
Received: 11 December 2020
Published: 30 April 2021
|
|
Corresponding Authors:
Yan-cheng CHEN,Run PU
E-mail: chenyc@most.gov.cn;purun@cncbd.org.cn
|
|
|
[1] |
封雪韵. 创新创业生态系统构成及其相互关系分析. 商业经济研究, 2017(4):124-126.
|
|
|
[1] |
Feng X Y. Analysis on the composition of innovation and entrepreneurship ecosystem and its relationship. Journal of Commercial Economics, 2017(4):124-126.
|
|
|
[2] |
常婷婷, 王秋实. 创新创业生态系统的运行机理研究. 信息通信技术与政策, 2019(3):7-9.
|
|
|
[2] |
Chang T T, Wang Q S. Research on the operation mechanism of innovation and entrepreneurship ecosystem. Information and Communications Technology and Policy, 2019(3):7-9.
|
|
|
[3] |
Gann D, Tackett M, Thorne C. Pathway to societal impact, a review of imperial college’s technology transfer, translation and related activities. London: Imperial College London, 2016: 19-21.
|
|
|
[4] |
张柳燕, 常素华, 王晶. 从首个合成细胞看合成生物学的现状与发展. 科学通报, 2010,55(36):3477-3488.
|
|
|
[4] |
Zhang L Y, Chang S H, Wang J. Current situation and development of synthetic biology from the perspective of the first synthetic cell. Chinese Science Bulletin, 2010,55(36):3477-3488.
|
|
|
[5] |
UK Synthetic Biology Roadmap Coordination Group. A synthetic biology roadmap for the UK. London: Technology Strategy Board on behalf of UK Synthetic Biology Roadma, 2012: 4-5.
|
|
|
[6] |
Clarke L J, Kitney R I. Synthetic biology in the UK - an outline of plans and progress. Synthetic and Systems Biotechnology, 2016,1(4):243-257.
pmid: 29062950
|
|
|
[7] |
张大璐. 英国生物技术成果转化经验及若干启示. 中国生物工程杂志, 2012,32(9):131-134.
|
|
|
[7] |
Zhang D L. Experience of British biotechnology achievements transformation and suggestions. China Biotechnology, 2012,32(9):131-134.
|
|
|
[8] |
濮润, 董丽娟, 唐尚锋, 等. 我国区域生物医药产业分工研究. 医药导报, 2019,38(10):1376-1378.
|
|
|
[8] |
Pu R, Dong L J, Tang S F, et al. Research on division of labor of regional biomedical industry in China. Herald of Medicine, 2019,38(10):1376-1378.
|
|
|
[9] |
尹政清, 白京羽, 林晓锋. 我国各区域生物产业竞争力评价及实证分析. 生物工程学报, 2020,36(10):2216-2225.
|
|
|
[9] |
Yin Z Q, Bai J Y, Lin X F. Assessment and empirical analysis of the competitiveness of bioindustry in various regions of China. Chinese Journal of Biotechnology, 2020,36(10):2216-2225.
|
|
|
[10] |
敖翼, 濮润, 展勇, 等. 我国新药创制的发展现状及问题浅析. 中国新药杂志, 2020,29(1):33-41.
|
|
|
[10] |
Ao Y, Pu R, Zhan Y, et al. Analysis on the status quo and problems of the development of new drugs in China. Chinese Journal of New Drugs, 2020,29(1):33-41.
|
|
|
[11] |
白京羽, 林晓锋, 丁俊琦. 我国生物产业发展现状及政策建议. 中国科学院院刊, 2020,35(8):1053-1060.
|
|
|
[11] |
Bai J Y, Lin X F, Ding J Q. Development status and policy suggestions of China’s biological industry. Bulletin of Chinese Academy of Sciences, 2020,35(8):1053-1060.
|
|
|
[12] |
林毅夫, 张军, 王勇, 等. 产业政策: 总结、反思与展望. 北京: 北京大学出版社, 2018: 33.
|
|
|
[12] |
Lin Y F, Zhang J, Wang Y, et al. Industrial policy: summary, reflection and prospect. Beijing: Peking University Press, 2018: 33.
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|